Cargando…

COVID-19 Repeated Convalescent Plasma Collection: Analysis of 149 Donations from 88 French Military Health Workers

BACKGROUND: Passive therapy with convalescent plasma (CP) could be an effective and safe treatment option in COVID-19 patients. Neutralizing antibodies present in CP generated in response to SARS-CoV-2 infection and directed against the receptor-binding domain of the spike protein are considered to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conan, Pierre-Louis, Ficko, Cécile, Chueca, Marine, Rolland, Carole, Javaudin, Olivier, Bigaillon, Christine, Durand, Guillaume-André, Leparc-Goffart, Isabelle, Verret, Catherine, Aletti, Marc, Dutasta, Fabien, Savini, Hélène, Bosson, Jean-Luc, Martinaud, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450834/ https://www.ncbi.nlm.nih.gov/pubmed/34580580 http://dx.doi.org/10.1159/000515843

Ejemplares similares

Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans
por: Martinaud, Christophe, et al.
Publicado: (2020)

Dengue Surveillance among French Military in Africa
por: de Laval, Franck, et al.
Publicado: (2012)

Donating convalescent plasma for COVID-19 patients
por: Black, Emily
Publicado: (2020)

1785. Infectious Etiologies for Post-Donation Deferrals in a Military Blood Donation Center
por: Kwon, Somin, et al.
Publicado: (2023)

Decay chain $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm
por: Cabrera, J A, et al.
Publicado: (1991)

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021)

Treatment–donation-stockpile dynamics in ebola convalescent blood transfusion therapy
por: Huo, Xi, et al.
Publicado: (2016)

MicroRNA-149 Suppresses Inflammation in Nucleus Pulposus Cells of Intervertebral Discs by Regulating MyD88
por: Qin, Chuqiang, et al.
Publicado: (2019)

Study of $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm decay chain
por: Cabrera, J A, et al.
Publicado: (1992)

Le paludisme en 2022 : aspects cliniques et thérapeutiques
por: FICKO, Cécile, et al.
Publicado: (2023)

NORWALK AND RELATED VIRUSES (CALICIVIRIDAE)
por: Estes, Mary K., et al.
Publicado: (1999)

MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88
por: Zhan, Yueping, et al.
Publicado: (2015)

The War and Voluntary Hospital Beds: Military Convalescents v. Urgent Cases
Publicado: (1915)

Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations
por: Jungbauer, Christof, et al.
Publicado: (2020)

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father
por: Vlachogianni, Glykeria, et al.
Publicado: (2020)

Letter to the editor: False-positive results with rapid diagnostic tests (RDT) for dengue
por: Javelle, Emilie, et al.
Publicado: (2019)

Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges
por: Peltzer, Juliette, et al.
Publicado: (2018)

1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
por: Joyner, Nancy M, et al.
Publicado: (2020)

Convalescent blood plasma (CBP) donated by recovered COVID-19 patients – A comment
por: Lung, Th., et al.
Publicado: (2021)

Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88
por: Xiang, Fenfen, et al.
Publicado: (2019)

Convalescent plasma for covid19 – How long should a donor be excluded from donation?
por: Kutner, Jose M., et al.
Publicado: (2020)

Self-interest or altruism: Entrepreneurs’ military experience and the motivation of corporate philanthropic donations
por: Chen, Huaichao, et al.
Publicado: (2022)

Emission channeling experiments from the decay of $^{149}$Gd to $^{149}$Eu in GaN
por: De Vries, B, et al.
Publicado: (2003)

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
por: Nguyen, Dung, et al.
Publicado: (2021)

Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea
por: Delamou, Alexandre, et al.
Publicado: (2016)

Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation
por: Maheshwari, A., et al.
Publicado: (2021)

Knowledge and Attitudes of Young Adults Towards Donation of COVID-19 Convalescent Plasma and Its Therapeutic Properties
por: Perenc, Lidia, et al.
Publicado: (2021)

Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells
por: Amri, Nada, et al.
Publicado: (2022)

149th SPSC Meeting
Publicado: (2023)

149th LHCC Meeting
Publicado: (2022)

Analysis of trapped mosquito excreta as a noninvasive method to reveal biodiversity and arbovirus circulation
por: L'Ambert, Grégory, et al.
Publicado: (2022)

Chikungunya Virus Infection
por: Simon, Fabrice, et al.
Publicado: (2011)

Variability of Zika Virus Incubation Period in Humans
por: Fourié, Toscane, et al.
Publicado: (2018)

Globalization of Chikungunya: 10 years to invade the world
por: Charrel, R. N., et al.
Publicado: (2014)

Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
por: Bousquet, Aurore, et al.
Publicado: (2022)

Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
por: Karbiener, Michael, et al.
Publicado: (2021)

Lateral ST-elevation myocardial infarction after donation of COVID-19 convalescent plasma in a naïve donor
por: Shams, Pirbhat, et al.
Publicado: (2021)

Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
por: Gontu, Abhinay, et al.
Publicado: (2021)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6suu0oho4vt3581kf39fal62fd